Zero Disruptions: Migrating 14 Mid-Study Clinical Trials In 16 Months

Established in 1907, Imperial College London boasts the highest concentration of high-impact research among major universities in the United Kingdom and holds the fourth position in the country for world-leading research.

Faced with the challenge of alleviating user burden, minimizing training and data management complexities, streamlining processes, and reducing costs, Imperial decided that it would need to modernize its electronic data capture (EDC) system. Traditionally, transitioning from one system to another involved maintaining ongoing studies in the existing system while initiating new studies in the new system. However, Imperial had multiple long-term ongoing studies and wished to avoid the additional costs and administrative complexities associated with managing two systems concurrently.

To address this, Imperial opted to utilize OpenClinica's established process to migrate 14 ongoing studies from its legacy system to the OpenClinica platform. This encompassed the transfer of their core EDC, Participate (ePRO), Insight (reporting), and Randomize functionalities.

Access the case study below to uncover how OpenClinica was able to effectively transfer 14 ongoing studies, encompassing over 1,700 patients and 150,000+ forms, onto the OpenClinica platform within 16 months.